Recursion licence of Tempus de-identified clinical and molecular records for AI model training, annual fee
$22.0 million and $42.0 million
USD per contract year (five-year term), US
“annual license fees during the Term ranging between $22.0 million and $42.0 million”
Recursion Pharmaceuticals Form 8-K, 9 November 2023 (Tempus master agreement), 2023-11
- Kind of source
- Regulatory filing
- Read on
- 2026-11-06
- Daily check
- Quote found at the source on 2026-11-06
- What to know
- Recursion pays Tempus. Access is capped: Recursion may download a maximum number of de-identified records at once, subject to an aggregate cap on unique records over the term.
Used in
Kept as evidence; no figure on the platform is computed from it yet.